Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical hydrocortisone ointment with serial meatal dilatation for meatal stricture in boys
IRCT20210729052011N1Phase 2Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydrocortisone in Urethral stenosis, sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Resolution of meatal stricture. Started Sep 2021; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Urethral stenosis
Beyond the preview
Go deeper on IRCT20210729052011N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210729052011N1.